Taxane Market: Can a Three-Decade-Old Chemotherapy Class Still...

ha aggiunto una foto Health

2026-07-22 09:27:31 -

Taxane Market: Can a Three-Decade-Old Chemotherapy Class Still Compete With Targeted Cancer Therapies?

The taxane market — a class of microtubule-stabilizing chemotherapy drugs including paclitaxel, docetaxel, and cabazitaxel, derived originally from yew tree compounds and used across breast, lung, ovarian, and prostate cancer treatment — continues to demonstrate resilient, steady growth despite the broader oncology industry's shift toward targeted therapies and immunotherapy, with...

0 Commenti 0 condivisioni 8 Views 0 Anteprima